1. Home
  2. RANI vs LRE Comparison

RANI vs LRE Comparison

Compare RANI & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • LRE
  • Stock Information
  • Founded
  • RANI 2012
  • LRE 2001
  • Country
  • RANI United States
  • LRE Japan
  • Employees
  • RANI N/A
  • LRE N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • LRE
  • Sector
  • RANI Health Care
  • LRE
  • Exchange
  • RANI Nasdaq
  • LRE Nasdaq
  • Market Cap
  • RANI 23.2M
  • LRE 24.0M
  • IPO Year
  • RANI 2021
  • LRE 2023
  • Fundamental
  • Price
  • RANI $0.55
  • LRE $1.44
  • Analyst Decision
  • RANI Strong Buy
  • LRE
  • Analyst Count
  • RANI 4
  • LRE 0
  • Target Price
  • RANI $7.75
  • LRE N/A
  • AVG Volume (30 Days)
  • RANI 1.1M
  • LRE 69.1K
  • Earning Date
  • RANI 08-07-2025
  • LRE 01-01-0001
  • Dividend Yield
  • RANI N/A
  • LRE N/A
  • EPS Growth
  • RANI N/A
  • LRE N/A
  • EPS
  • RANI N/A
  • LRE N/A
  • Revenue
  • RANI $1,200,000.00
  • LRE $110,330,328.00
  • Revenue This Year
  • RANI N/A
  • LRE N/A
  • Revenue Next Year
  • RANI N/A
  • LRE N/A
  • P/E Ratio
  • RANI N/A
  • LRE N/A
  • Revenue Growth
  • RANI N/A
  • LRE 3.92
  • 52 Week Low
  • RANI $0.39
  • LRE $1.10
  • 52 Week High
  • RANI $3.75
  • LRE $2.49
  • Technical
  • Relative Strength Index (RSI)
  • RANI 53.01
  • LRE 40.26
  • Support Level
  • RANI $0.50
  • LRE $1.34
  • Resistance Level
  • RANI $0.59
  • LRE $1.63
  • Average True Range (ATR)
  • RANI 0.04
  • LRE 0.14
  • MACD
  • RANI 0.00
  • LRE -0.03
  • Stochastic Oscillator
  • RANI 63.16
  • LRE 13.68

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

Share on Social Networks: